A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo

NCT06118411 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

614

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: Upadacitinib
DRUG: Placebo
OTHER: NB-UVB (narrow-band ultraviolet B) Phototherapy

Sponsor

AbbVie